Identification of novel biomarkers for malignant pleural mesothelioma by proteomics of serum exosomes

被引：0
|
作者：
Abe, Yuko [1 ]
Takeda, Yoshito [1 ]
Enomoto, Takatoshi [1 ]
Yoshimura, Hanako [1 ]
Suga, Yasuhiko [1 ]
Fukushima, Kiyoharu [1 ]
Shiroyama, Takayuki [1 ]
Hirata, Haruhiko [1 ]
Yokoi, Takashi [2 ]
Minami, Toshiyuki [2 ]
Kuribayashi, Kozo [2 ]
Kijima, Takashi [2 ]
Kumanogoh, Atsushi [1 ]
机构：
[1] Med Osaka Univ, Dept Resp Med Clin Immunol Med, Osaka, Japan
[2] Hyogo Coll Med, Div Resp Med, Tokyo, Japan
来源：
CANCER SCIENCE | 2022年 / 113卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P14-11-5
引用
收藏
页码：584 / 584
页数：1
相关论文
共 50 条
  • [21] Biomarkers for Malignant Pleural Mesothelioma Current Status
    Greillier, Laurent
    Baas, Paul
    Welch, John J.
    Hasan, Baktiar
    Passioukov, Alexandre
    MOLECULAR DIAGNOSIS & THERAPY, 2008, 12 (06) : 375 - 390
  • [22] Biomarkers and prognostic factors for malignant pleural mesothelioma
    Vigneri, Paolo
    Martorana, Federica
    Manzella, Livia
    Stella, Stefania
    FUTURE ONCOLOGY, 2015, 11 (24) : 29 - 33
  • [23] An Early Detection and Prognostic Blood Biomarkers Signature for Malignant Pleural Mesothelioma Based on Targeted Proteomics
    Cerciello, F.
    Choi, M.
    Sinicropi-Yao, S.
    Lomeo, K.
    Amann, J.
    Felley-Bosco, E.
    Stahel, R.
    Wa, U.
    Creaney, J.
    Pass, H.
    Vitek, O.
    Carbone, D.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S199 - S200
  • [24] Target Proteomics Identifies Novel Biomarkers from Serum Exosomes in Sarcoidosis
    Futami, Y.
    Takeda, Y.
    Koba, T.
    Edahiro, R.
    Shirai, Y.
    Hirata, H.
    Nagatomo, I.
    Kuroyama, M.
    Narumi, R.
    Adachi, J.
    Tomonaga, T.
    Ueda, K.
    Kumanogoh, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [25] Assessment of signaling pathway inhibitors and identification of predictive biomarkers in malignant pleural mesothelioma
    Tranchant, Robin
    Quetel, Lisa
    Montagne, Francois
    De Wolf, Julien
    Meiller, Clement
    De Koning, Leanne
    Le Pimpec-Barthes, Francoise
    Zucman-Rossi, Jessica
    Jaurand, Marie-Claude
    Jean, Didier
    LUNG CANCER, 2018, 126 : 15 - 24
  • [26] LOX and ZFPM2 as novel diagnostic biomarkers for malignant pleural mesothelioma
    Kim, Minkyu
    Kim, Hyun-Won
    Jung, Soon-Hee
    Oh, Sung Soo
    Jeong, Yangsik
    Choi, Jong-Whan
    CANCER RESEARCH, 2017, 77
  • [27] A Novel Proteomic Technique Uncovers New Diagnostic Biomarkers for Malignant Pleural Mesothelioma
    Lamote, K.
    Schillebeeckx, E.
    Fernandez, E.
    Staes, A.
    van Meerbeeck, J. P.
    Gevaert, K.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S391 - S391
  • [28] NOVEL THERAPIES FOR MALIGNANT PLEURAL MESOTHELIOMA
    Sterman, Daniel H.
    RESPIROLOGY, 2010, 15 : 15 - 15
  • [29] Novel therapies for malignant pleural mesothelioma
    Scherpereel, Arnaud
    Wallyn, Frederic
    Albelda, Steven M.
    Munck, Camille
    LANCET ONCOLOGY, 2018, 19 (03): : E161 - E172
  • [30] Prognostic Biomarkers for Malignant Pleural Mesothelioma Treated with Chemotherapy
    Akgun, Hakan
    Metintas, Selma
    Ak, Guntulu
    Demirkol, Secil
    Aydin, Resat
    Isbilen, Murat
    Gure, Ali
    Metintas, Muzaffer
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1369 - S1369
12345